A practical gift for someone who always wants to be prepared.

Scientists at The University of Texas at El Paso have found a promising new target in the fight against high-grade serous ...

In light of the high-quality remakes of Resident Evil 2 and 3 released in 2019 and 2020, it felt like a safe bet that Capcom would do an equally admirable job of rebuilding Resident Evil 4. Even so, ...

The share price of Danish pharmaceutical giant Novo Nordisk ( NVO +1.31%) hit a four-year low Monday, falling below $44 a ...

President Donald Trump announced Friday that he was canceling executive orders signed using President Joe Biden’s autopen. Like other presidents, including Trump, Biden used an autopen to sign certain ...

X4 Pharmaceuticals’ Mavorixafor could become a safer treatment for CN and the 4WARD Phase 3 trial in CN will be key. Click ...

Analysts at Guggenheim Partners expect Voyxact to see “broad commercial uptake” given its relatively broad label compared ...

Novo Nordisk A/S acquires Zaltenibart for $2.1B, targeting rare diseases. NVO shares present a de-risked entry point. Click for this updated look at NVO stock.

Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. CNBC Select will update as changes are made public.

Enhanced angioplasty with focal force technology now offers a proven path to achieving more effective and durable results.